Limit search to available items
Book Cover
Author Becker, Richard C

Title Antithrombotic therapy in the prevention of ischemic stroke / by Richard C. Becker, Frederick A. Spencer
Published Oxford ; New York : Oxford University Press, 2010


Description 1 online resource (45 pages) : illustrations
Series Oxford American pocket notes
Oxford American pocket notes.
Contents Cover; Contents; Introduction and Epidemiology; Pathophysiology; Regulatory Factors in Thrombus Formation; Cellular Interactions in Atherothrombosis; Classification of Stroke; Managing Risk Factors for Recurrent Stroke; Antithrombotic Therapy for Prevention of Recurrent TIA and Stroke; Aspirin; Mechanism of Action; Pharmacokinetics; Adverse Effects; Aspirin Administration in Clinical Practice; Secondary Prevention of Vascular Events and Stroke; Aspirin Dosing in Prevention of Recurrent TIA/Stroke; Thienopyridines (Clopidogrel, Ticlopidine, and Prasugrel); Mechanism of Action; Clopidogrel
PharmacokineticsAbsorption; Adverse Effects; Prevention of Vascular Events; Ticlopidine; Prasugrel; Dipyridamole, Extended-Release Dipyridamole/Aspirin Combination (Aggrenox); Mechanism of Action; Pharmacokinetics; Pharmacodynamics; Adverse Effects; Administration in Older Patients; Clinical Experience; Cilostazol; References
Summary Stroke is the most common cause of adult mortality in the United States. Antithrombotic agents form the mainstay of stroke prevention. Aspirin produces a modest reduction in the risk of second stroke and transient ischemic attack (TIA, mini-stroke) and is widely recommended for initial therapy. The thienopyridines (Ticlid) and clopodogrel (Plavix) are alternatives for secondary prevention in patients who do not respond to or cannot take aspirin. They are no more effective than aspirin and have been associated with thrombotic thrombocytopenic purpura. The combination of aspirin and extended-rel
Bibliography Includes bibliographical references
Notes English
Print version record
Subject Transient ischemic attack -- Chemotherapy
Transient ischemic attack -- Prevention
Fibrinolytic agents.
Ischemic Attack, Transient -- drug therapy
Ischemic Attack, Transient -- prevention & control
Fibrinolytic Agents
HEALTH & FITNESS -- Diseases -- General.
MEDICAL -- Clinical Medicine.
MEDICAL -- Diseases.
MEDICAL -- Evidence-Based Medicine.
MEDICAL -- Internal Medicine.
Fibrinolytic agents
Form Electronic book
Author Spencer, Fredrick A., MD.
ISBN 9780199774449